|

Nivolumab and Recombinant Human Hyaluronidase Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Hyaluronidase-nvhy and Nivolumab, Hyaluronidase/Nivolumab, Nivolumab and Hyaluronidase-nvhy, Nivolumab and rHuPH20, Nivolumab/Recombinant Human Hyaluronidase +2 more

Pipeline

Phase 3: 1

Top Sponsors

  • SWOG Cancer Research Network1

Indications

  • Advanced Clear Cell Renal Cell Carcinoma1
  • Metastatic Clear Cell Renal Cell Carcinoma1
  • Stage IV Renal Cell Cancer AJCC v81
  • Stage III Renal Cell Cancer AJCC v81
  • Cancer1

Fayetteville, Arkansas1 trial

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

Highlands Oncology Group - Fayetteville

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.